BN Business News
Add your company to Business Communicator →

Business · 29/05/2026

FDA Renews Psychopharmacologic Drugs Advisory Committee for 2 Years

The FDA has renewed the Psychopharmacologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2028.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights